Longduoduo (LDDD) Net Equity Issued and Repurchased (2021 - 2022)

Longduoduo (LDDD) posted quarterly Net Equity Issued and Repurchased of -$246.0 for Q2 2022, down 283.58% quarter-over-quarter from $134.0 in Q1 2022.

Longduoduo (LDDD) Net Equity Issued and Repurchased (2021 - 2022) Analysis & Trends

Longduoduo's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$246.0 for Q2 2022.

  • In Q2 2022, Net Equity Issued and Repurchased changed N/A year-over-year to -$246.0; the TTM figure through Jun 2022 stood at $30982.0 (changed N/A YoY), while the FY2022 annual figure was $30982.0, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q2 2022 stood at -$246.0, down from $134.0 in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $30909.0 in Q3 2021, with the low at -$246.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 Longduoduo 15.31 Mn 14.14 Mn 184,055.00 -

Historic Data

Download Data
DateValue
Jun 30, 2022 -246.00
Jun 30, 2022 -246.00
Mar 31, 2022 134.00
Mar 31, 2022 134.00
Dec 31, 2021 185.00
Dec 31, 2021 185.00
Sep 30, 2021 30,909.00
Sep 30, 2021 30,909.00